Literature DB >> 2959570

Transferrin and somatomedin C receptors in the human ovarian follicles.

G C Balboni1, G B Vannelli, T Barni, C Orlando, M Serio.   

Abstract

Transferrin and somatomedin C receptors (TFr and SMCr) were studied in human ovaries by immunostaining using monoclonal antisera. The oocyte of evoluting follicles was intensely positive for both types of receptors, but this positivity decreases in large follicles. An evident positivity for both TFr and SMCr was shown in granulosa cells of evoluting follicles. However, not all of these cells were equally immunoreactive. An intense positivity was present in the developing thecal cells of early cavitary follicles as well as in thecal cells of follicles of medium and large size (greater than 6 mm) and in some cells of involuting follicles in initial atresia. These results seem to demonstrate that TFr and SMCr are present in different cellular components of the human developing and early involuting follicles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959570     DOI: 10.1016/s0015-0282(16)59533-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Growth hormone--a cogonadotropin? Its role in ovulation induction.

Authors:  Z Blumenfeld
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

Review 2.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 3.  The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review.

Authors:  Dylan L Petkus; Laura E Murray-Kolb; Mary Jane De Souza
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

4.  Developmental regulation of the expression of the transferrin receptor and Ki67 in oocytes of the baboon fetal ovary by estrogen.

Authors:  Marcia G Burch; Chunhua Li; Eugene D Albrecht; Gerald J Pepe
Journal:  Endocrine       Date:  2009-01-21       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.